BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10802616)

  • 1. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies.
    De La Vega FM; Dailey D; Ziegle J; Williams J; Madden D; Gilbert DA
    Biotechniques; 2002 Jun; Suppl():48-50, 52, 54. PubMed ID: 12083398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common deletions and SNPs are in linkage disequilibrium in the human genome.
    Hinds DA; Kloek AP; Jen M; Chen X; Frazer KA
    Nat Genet; 2006 Jan; 38(1):82-5. PubMed ID: 16327809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic analysis of clinically relevant genetic polymorphisms.
    McLeod HL
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S449-52. PubMed ID: 16237646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNPs and haplotypes: genetic markers for disease and drug response (review).
    Shastry BS
    Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in high-density whole genome-wide single nucleotide polymorphism array in cancer research].
    Zeng ZY; Xiong W; Zhou YH; Li XL; Li GY
    Ai Zheng; 2006 Nov; 25(11):1454-8. PubMed ID: 17094921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis and application of SNP and haplotype in the human genome].
    Li J; Pan YC; Li YX; Shi TL
    Yi Chuan Xue Bao; 2005 Aug; 32(8):879-89. PubMed ID: 16231744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single SNPs, haplotypes, and whole-genome LD maps on accuracy of association mapping.
    Maniatis N; Collins A; Morton NE
    Genet Epidemiol; 2007 Apr; 31(3):179-88. PubMed ID: 17285621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets.
    Zeggini E; Rayner W; Morris AP; Hattersley AT; Walker M; Hitman GA; Deloukas P; Cardon LR; McCarthy MI
    Nat Genet; 2005 Dec; 37(12):1320-2. PubMed ID: 16258542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers.
    Ohashi J; Tokunaga K
    J Hum Genet; 2001; 46(8):478-82. PubMed ID: 11501946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics.
    Stephens JC
    Mol Diagn; 1999 Dec; 4(4):309-17. PubMed ID: 10671641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of different density SNP maps for disease association studies of common variants.
    Wang WY; Todd JA
    Hum Mol Genet; 2003 Dec; 12(23):3145-9. PubMed ID: 14532327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of estimates of SNP and haplotype diversity and linkage disequilibrium in samples from the same population due to experimental and evolutionary sample size.
    Visscher PM
    Ann Hum Genet; 2007 Jan; 71(Pt 1):119-26. PubMed ID: 17227482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome.
    Tsunoda T; Lathrop GM; Sekine A; Yamada R; Takahashi A; Ohnishi Y; Tanaka T; Nakamura Y
    Hum Mol Genet; 2004 Aug; 13(15):1623-32. PubMed ID: 15190013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primer: SNP-associated studies and what they can teach us.
    Yamada R
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):210-7. PubMed ID: 18319711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNP databases and pharmacogenetics: great start, but a long way to go.
    Marsh S; Kwok P; McLeod HL
    Hum Mutat; 2002 Sep; 20(3):174-9. PubMed ID: 12203989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms and implications for human diseases.
    Sripichai O; Fucharoen S
    J Med Assoc Thai; 2007 Feb; 90(2):394-8. PubMed ID: 17375650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MedRefSNP: a database of medically investigated SNPs.
    Rhee H; Lee JS
    Hum Mutat; 2009 Mar; 30(3):E460-6. PubMed ID: 19105187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.